Danhua Chemical Technology Co (900921) Fair Value & Analysis
Basic Materials · CN · Market cap $168M
Fair value as of: Jun 26, 2026
Analysis
Danhua Chemical Technology Co (900921) currently trades at $0.1630, while our model-based Fair Value estimate is $0.0400 — implying the stock looks roughly 75.5% overvalued today. We read business quality at 83/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Danhua Chemical Technology Co.,Ltd, together with its subsidiaries, engages in the production and sale of coal chemical products in China. The company's products include ethylene glycol and oxalic acid that are primarily used to manufacture polyester, polyester resin, desiccant, surfactant, plasticizer, synthetic fiber, cosmetics, and explosives. It also offers dehydrogenation catalysts, synthesis catalysts, and hydrogenation catalysts, as well as dimethyl oxalate, copper-palladium powder alloy, alloy material, activated carbon, and adsorbent and its derivatives. In addition, the company engages in the technology development, technology transfer, and technology consulting in the field of energy and chemical industry; production of plastic product; and material technology development, consulting, transfer, and promotion activities. The company was founded in 1993 and is based in Danyang, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Danhua Chemical Technology Co (900921) undervalued?
What is the fair value of 900921?
What is the quality score of 900921?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.